Health ❯ Clinical Research

Drug Efficacy

Clinical Trials Side Effects Phase Trials Weight Loss Treatments Patient Outcomes Weight Loss Studies Weight Loss Medications Regulatory Affairs Alcohol Consumption Weight Loss Statistical Significance GLP-1 Weight Loss Solutions Anxiety Treatment Studies Binding Affinity Cirrhosis Treatment HIV Treatment Placebo Effects Alzheimer's Disease HIV Studies Patient Response Weight Loss Therapies Muscle Preservation Weight Loss Trials Toxicology

Enzyme Platform Produces Promising, Less-Toxic Polyene Candidate Nys34

Researchers used genome mining with enzyme-guided sugar addition and amidation to make polyenes more soluble and potent.

Oral GLP‑1 Approval and New Trials Push Weight‑Loss Drugs Into Mass Market

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

Structure Therapeutics' Oral GLP-1 Posts Up to 15% Placebo-Adjusted Weight Loss as Company Prepares Phase 3

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Albumin-PLGA Nanoparticles Enable Ultrahigh Drug Loading and Six-Month Stability